About Supriya Lifescience Limited
Supriya Lifescience Limited (SLL) is an API manufacturer (Active Pharmaceutical Ingredients) with a portfolio of 38 APIs and is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. The company has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between Fiscal 2017 and 2021. The company is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021 in terms of volume.
In Fiscal 2021, the company’s products were exported to 86 countries to 1,296 customers including 346 distributors. The company has API business in Europe, Latin America, Asia, and North America.
Supriya Lifescience has a modern manufacturing facility in Maharashtra spread across 23,806 sq. mts, having a reactor capacity of 547 KL/ day including 7 clean rooms. The company has also acquired a plot of land, admeasuring 12,551 sq. mt, near the present manufacturing facility, to expand its manufacturing infrastructure. The company’s manufacturing facility has received approvals from USFDA, EDQM TGA-Australia, KFDA-Korea, PMDA Japan, NMPA (previously known as SFDA)- China, Health Canada, in relation to API products being exported to the relevant jurisdictions by the company.
Supriya Lifescience Limited – IPO Timetable
| IPO Open Date | Dec 16, 2021 |
| IPO Close Date | Dec 20, 2021 |
| Basis of Allotment Date | Dec 23, 2021 |
| Initiation of Refunds | Dec 24, 2021 |
| Credit of Shares to Demat Account | Dec 27, 2021 |
| IPO Listing Date | Dec 28, 2021 |
Price band of the book built issue has been fixed at ₹265 to ₹274 per equity share. The IPO market lot size is 54 shares. A retail-individual investor can apply for up to 13 lots (702 shares or ₹192,348).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 54 | ₹14,796 |
| Maximum | 13 | 702 | ₹192,348 |
The Grey Market Premium (GMP ) is being quoted at around 290 ₹ , so assuming you get the shares at the upper band of ₹ 274 , the listing is going to be at more than double that amount at around 274+290 = ₹ 564 (105.84%)
What this means is that you get to double your investment in less than 15 days (provided your bid is accepted :))
About the Author
